Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Dec. 13 to 17, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Dec. 13 to 17, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Severe Mental Illness Tied to Poorer COVID-19 Outcomes
FRIDAY, Dec. 17, 2021 (HealthDay News) — People with severe mental illness have higher risks for COVID-19 infection, hospitalization, and mortality, according to a study published online Dec. 7 in Molecular Psychiatry.
Pfizer Vaccine Disappoints in Children Ages 2 to 5 Years
FRIDAY, Dec. 17, 2021 (HealthDay News) — Two doses of a pediatric Pfizer-BioNTech COVID-19 vaccine failed to spur an adequate immune response in children ages 2 to 5 years, the companies announced Friday.
Myocarditis, Myopericarditis Risk Up After SARS-CoV-2 Vaccination
FRIDAY, Dec. 17, 2021 (HealthDay News) — SARS-CoV-2 mRNA vaccination is associated with a significantly increased risk for myocarditis or myopericarditis among males and females receiving mRNA-1273 and among females receiving BNT162b2, but absolute rates are low, according to a study published online Dec. 16 in The BMJ.
Hyperbaric Oxygen Helps Treat Severe Hypoxemia in COVID-19
FRIDAY, Dec. 17, 2021 (HealthDay News) — Hyperbaric oxygen therapy is effective for patients with severe hypoxemia associated with COVID-19, according to a study published online Dec. 14 in the Emergency Medicine Journal.
COVID-19 Vaccination More Likely With Provider Recommendation
THURSDAY, Dec. 16, 2021 (HealthDay News) — Adults who receive a provider recommendation for COVID-19 vaccination are more likely to have received one or more doses of COVID-19 vaccine, according to research published in the Dec. 17 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Early CDC COVID-19 Tests Were Not Only Contaminated, but Flawed
THURSDAY, Dec. 16, 2021 (HealthDay News) — Along with being contaminated, there was also a basic design flaw in COVID-19 testing kits created by the U.S. Centers for Disease Control and Prevention early in the pandemic, a new agency review shows.
CDC Panel Advises That Other Vaccines Are Preferred Over J&J Shot
THURSDAY, Dec. 16, 2021 (HealthDay News) — Following continued reports of a rare but life-threatening clotting condition linked to the Johnson & Johnson COVID-19 vaccine, a federal advisory panel on Thursday recommended that the Pfizer and Moderna shots be the preferred choices for Americans.
U.S. Army COVID-19 Vaccination Rate Nears 98 Percent
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
Most U.S. Adults Unsure Which Vaccines CDC Recommends During Pregnancy .jpg)
Pregnancy Complications Rare for Women Receiving CAR T-Cell Therapy 
Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
